The value of preoperative screening colonoscopies in patients with biliary tract cancer

Journal of Gastroenterology

Volumn 51, Issue 2, 2016, Pages 138-143

  Itatsu, Keita ^a   Yokoyama, Yukihiro ^a   Ebata, Tomoki ^a   Igami, Tsuyoshi ^a   Sugawara, Gen ^a   Uehara, Keisuke ^a   Mizuno, Takashi ^a   Ando, Masahiko ^b   Goto, Hidemi ^a   Nagino, Masato ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Biliary tract cancer; Cholangiocarcinoma; Colonoscopy; Colorectal cancer; Synchronous neoplasia

Indexed keywords

ADULT; AGED; ARTICLE; BILE LEAKAGE; BILIARY TRACT CANCER; BILIARY TRACT DRAINAGE; BLEEDING; CHOLANGITIS; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CARCINOMA; COLORECTAL TUMOR; ENDOSCOPIC SURGERY; FEMALE; HISTOLOGY; HUMAN; INTESTINE PERFORATION; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; NEUROGENIC BLADDER; PANCREAS FISTULA; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RISK FACTOR; ADVERSE EFFECTS; AGE; BILIARY TRACT NEOPLASMS; COLORECTAL NEOPLASMS; EARLY CANCER DIAGNOSIS; EVALUATION STUDY; FEASIBILITY STUDY; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; PREOPERATIVE CARE; PROCEDURES; RETROSPECTIVE STUDY; SMOKING; VERY ELDERLY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BILIARY TRACT NEOPLASMS; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING;

EID: 84957435622     PISSN: 09441174     EISSN: 14355922     Source Type: Journal    
DOI: 10.1007/s00535-015-1092-x     Document Type: Article

References (43)

1. Nagino M, Ebata T, Yokoyama Y, et al. Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections. Ann Surg. 2013;258:129–40.
2. Ebata T, Yokoyama Y, Igami T, et al. Hepatopancreatoduodenectomy for cholangiocarcinoma: a single-center review of 85 consecutive patients. Ann Surg. 2012;256:297–305.
3. Sugawara G, Nagino M, Nishio H, et al. Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized controlled trial. Ann Surg. 2006;244:706–14.
4. Nagino M, Kamiya J, Nishio H, et al. Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up. Ann Surg. 2006;243:364–72.
5. Kawashima H, Itoh A, Ohno E, et al. Preoperative endoscopic nasobiliary drainage in 164 consecutive patients with suspected perihilar cholangiocarcinoma: a retrospective study of efficacy and risk factors related to complications. Ann Surg. 2013;257:121–7.
6. Ebata T, Nagino M, Kamiya J, et al. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases. Ann Surg. 2003;238:720–7.
7. Nagino M, Nimura Y, Nishio H, et al. Hepatectomy with simultaneous resection of the portal vein and hepatic artery for advanced perihilar cholangiocarcinoma: an audit of 50 consecutive cases. Ann Surg. 2010;252:115–23.
8. Nishio H, Ebata T, Yokoyama Y, et al. Gallbladder cancer involving the extrahepatic bile duct is worthy of resection. Ann Surg. 2011;253:953–60.
9. Okusaka T, Nakachi K, Fukutomi A, et al. Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan. Br J Cancer. 2010;103:469–74.
10. Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006;6:17–32.
11. Riall TS, Stager VM, Nealon WH, et al. Incidence of additional primary cancers in patients with invasive intraductal papillary mucinous neoplasms and sporadic pancreatic adenocarcinomas. J Am Coll Surg. 2007;204:803–13, Discussion 13−4.
12. Ueno M, Muto T, Oya M, et al. Multiple primary cancer: an experience at the Cancer Institute Hospital with special reference to colorectal cancer. Int J Clin Oncol. 2003;8:162–7.
13. Saito S, Hosoya Y, Togashi K, et al. Prevalence of synchronous colorectal neoplasms detected by colonoscopy in patients with gastric cancer. Surg Today. 2008;38:20–5.
14. Eom BW, Lee HJ, Yoo MW, et al. Synchronous and metachronous cancers in patients with gastric cancer. J Surg Oncol. 2008;98:106–10.
15. Lee JH, Bae JS, Ryu KW, et al. Gastric cancer patients at high-risk of having synchronous cancer. World J Gastroenterol. 2006;12:2588–92.
16. Yoo HM, Gweon TG, Seo HS, et al. Role of preoperative colonoscopy in patients with gastric cancer: a case control study of the prevalence of coexisting colorectal neoplasms. Ann Surg Oncol. 2013;20:1614–22.
17. Park DI, Park SH, Yoo TW, et al. The prevalence of colorectal neoplasia in patients with gastric cancer: a Korean Association for the Study of Intestinal Disease (KASID) Study. J Clin Gastroenterol. 2010;44:102–5.
18. Kim HO, Hwang SI, Yoo CH, et al. Preoperative colonoscopy for patients with gastric adenocarcinoma. J Gastroenterol Hepatol. 2009;24:1740–4.
19. Yoon SN, Oh ST, Lim SB, et al. Clinicopathologic characteristics of colorectal cancer patients with synchronous and metachronous gastric cancer. World J Surg. 2010;34:2168–76.
20. World Health Organization. Pathology and genetics of tumours of the digestive system. Lyon: IARC Press; 2000.
21. Schulmann K, Reiser M, Schmiegel W. Colonic cancer and polyps. Best Pract Res Clin Gastroenterol. 2002;16:91–114.
22. Kim SY, Jung SW, Hyun JJ, et al. Is colonoscopic screening necessary for patients with gastric adenoma or cancer? Dig Dis Sci. 2013;58:3263–9.
23. Watanabe T, Itabashi M, Shimada Y, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. Int J Clin Oncol. 2012;17:1–29.
24. Saito H. Screening for colorectal cancer: current status in Japan. Dis Colon Rectum. 2000;43:S78–84.
25. Morikawa T, Kato J, Yamaji Y, et al. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology. 2005;129:422–8.
26. Zauber AG, Winawer SJ, O’Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med. 2012;366:687–96.
27. Yoshinaga M, Motomura S, Takeda H, et al. Evaluation of the sensitivity of an immunochemical fecal occult blood test for colorectal neoplasia. Am J Gastroenterol. 1995;90:1076–9.
28. Lieberman D. Colorectal cancer screening: practice guidelines. Dig Dis. 2012;30[Suppl 2]:34–8.
29. Johnson CD, Chen MH, Toledano AY, et al. Accuracy of CT colonography for detection of large adenomas and cancers. N Engl J Med. 2008;359:1207–17.
30. Atkin W, Dadswell E, Wooldrage K, et al. Computed tomographic colonography versus colonoscopy for investigation of patients with symptoms suggestive of colorectal cancer (SIGGAR): a multicentre randomised trial. Lancet. 2013;381:1194–202.
31. American Institute for Cancer Research/World Cancer Research Fund. Food, nutrition, physical activity and the prevention of cancer: a global perspective. Washington, DC: American Institute for Cancer Research; 2007.
32. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology. 2008;134:1570–95.
33. Lim SB, Jeong SY, Choi HS, et al. Synchronous gastric cancer in primary sporadic colorectal cancer patients in Korea. Int J Colorectal Dis. 2008;23:61–5.
34. Lee WS, Lee JN, Choi S, et al. Multiple primary malignancies involving colorectal cancer—clinical characteristics and prognosis with reference to surveillance. Langenbecks Arch Surg. 2010;395:359–64.
35. World Health Organization. WHO classification of tumors of the digestive system. 4th ed. Lyon: IARC Press; 2010.
36. Patel T. Worldwide trends in mortality from biliary tract malignancies. BMC Cancer. 2002;2:10.
37. Castro FA, Koshiol J, Hsing AW, et al. Biliary tract cancer incidence in the United States—demographic and temporal variations by anatomic site. Int J Cancer. 2013;133:1664–71.
38. Doucas H, Garcea G, Neal CP, et al. Changes in the Wnt signalling pathway in gastrointestinal cancers and their prognostic significance. Eur J Cancer. 2005;41:365–79.
39. Itatsu K, Zen Y, Ohira S, et al. Immunohistochemical analysis of the progression of flat and papillary preneoplastic lesions in intrahepatic cholangiocarcinogenesis in hepatolithiasis. Liver Int. 2007;27:1174–84.
40. Burmer GC, Loeb LA. Mutations in the KRAS2 oncogene during progressive stages of human colon carcinoma. Proc Natl Acad Sci USA. 1989;86:2403–7.
41. Lagergren J, Ye W, Ekbom A. Intestinal cancer after cholecystectomy: is bile involved in carcinogenesis? Gastroenterology. 2001;121:542–7.
42. Fukase K, Kato M, Kikuchi S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet. 2008;372:392–7.
43. Graham DY, Asaka M. Eradication of gastric cancer and more efficient gastric cancer surveillance in Japan: two peas in a pod. J Gastroenterol. 2010;45:1–8.